Medicare AdvantageMay 13, 2025
Clinical Criteria updates
Effective June 20, 2025
Summary: The Pharmacy and Therapeutics (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.
Visit our Clinical Criteria page to find specific policies. If you have questions or need additional information, please email us.
Please see the explanation/definition for each category of Clinical Criteria below:
- New: newly published criteria
- Revised: addition or removal of medical necessity requirements, new document number
Please share this notice with other members of your practice and office staff.
Note:
- The Clinical Criteria listed below apply only to the medical drug benefits contained within the member’s medical plan. This does not apply to pharmacy services.
- This notice is meant to provide information on new or revised criteria that have been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.
Effective date | Clinical Criteria number | Clinical Criteria title | Status |
June 20, 2025 | CC-0282 | Onapgo (apomorphine subcutaneous solution) | New |
June 20, 2025 | CC-0149 | Select Clotting Agents for Bleeding Disorders | Revised |
June 20, 2025 | CC-0037 | Kanuma (sebelipase alfa) | Revised |
June 20, 2025 | CC-0159 | Scenesse (afamelanotide) | Revised |
June 20, 2025 | CC-0245 | Izervay (avacincaptad pegol) | Revised |
June 20, 2025 | CC-0197 | Jemperli (dostarlimab-gxly) | Revised |
June 20, 2025 | CC-0106 | Erbitux (cetuximab) | Revised |
June 20, 2025 | CC-0027 | Denosumab | Revised |
June 20, 2025 | CC-0066 | Monoclonal Antibodies to Interleukin-6 | Revised |
Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CR-083392-25-CPN82744
PUBLICATIONS: June 2025 Provider Newsletter
To view this article online:
Visit https://providernews.anthem.com/nevada/articles/clinical-criteria-updates-25178
Or scan this QR code with your phone